Samsung Bioepis Co., Ltd. vs. Regeneron Pharmaceuticals, Inc.

Explore the PTAB proceeding IPR2023-00442 filed by Samsung Bioepis Co., Ltd. on 2023-01-06. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00442

Filing Date

2023-01-06

Accorded Filing Date

2023-01-06

Institution Decision Date

2023-07-19

Last Modified Date

2024-08-23

Proceeding Type

IPR

Termination Date

2024-06-14

Trial Status

Final Written Decision

Parties & Counsel

Petitioner

Samsung Bioepis Co., Ltd.

Represented By

Nimrod, Raymondet al

Patent Owner / Respondent

Regeneron Pharmaceuticals, Inc.

Represented By

Fishman, Deborahet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 15471506

Respondent Patent Number 10130681

External Links

Espacenet

Google Patents

Respondent Inventor George D. YANCOPOULOS

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

23 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name A&P - Regeneron (Prosecution)

Customer Number 191459

Address 601 Massachusetts Ave., NW, Washington, DC, 20001-3743, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
41408	David Marsh	202-942-5068
48001	Thomas Triolo	914-847-1612
48921	Stephen Gaudet	914-847-7376
50370	Neil Miyamoto	914-847-7175
50437	Frank Cottingham	914-593-1116
58583	Brian Cocca	914-847-1421
58714	Ilona Gont	914-847-1304
59668	Brandon Schurter	914-847-7000
60281	Aparna Patankar	914-847-5571
61391	Yonghao Hou	914-839-2555
61915	Yongjin Choi	914-847-5384
65789	Margarita Zippin	914-847-5589
65957	Lisa Flanagan	914-847-8175
67881	Eileen Woo	914-847-1246
68046	Elysa Goldberg	914-847-1280
68059	David Mellman	720-391-8767
68136	Christopher Westberg	914-847-7912
71406	Gabriele Amodeo	914-847-3578
73212	Trisha Agrawal	914-313-7694
74751	Casey Donahoe	814-931-8622
76829	Michael Lewis	202-942-6728
77536	Alyson Nickols	640-448-3073
81783	Alice Ho	202-942-6753

Proceeding Documents

200

Dismissing in Part and Denying in Part Patent Owner’s Motion to Exclude Evidence 37 C.F.R. § 42.64(c) Determining Challenged Claims 1, 3–11, 13, 14, 16–24, and 26 Unpatentable 35 U.S.C. § 318(a) FINAL

2024-06-14 FILING PARTY: BOARD

Download

Other: Hearing transcript OTHER

2024-05-20 FILING PARTY: BOARD

Download

3002

Exhibit 3002 Exhibit

2024-04-29 FILING PARTY: BOARD

Download

3001

Exhibit 3001 Exhibit

2024-04-18 FILING PARTY: BOARD

Download

Patent Owner's Statement of Objections to Petitioner's Demonstratives OTHER

2024-04-17 FILING PARTY: PATENT OWNER

Download

Samsung Bioepis Co., Ltd. vs. Regeneron Pharmaceuticals, Inc.

Proceeding Overview

Parties & Counsel

Petitioner

Samsung Bioepis Co., Ltd.

Represented By

Patent Owner / Respondent

Regeneron Pharmaceuticals, Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Dismissing in Part and Denying in Part Patent Owner’s Motion to Exclude Evidence 37 C.F.R. § 42.64(c) Determining Challenged Claims 1, 3–11, 13, 14, 16–24, and 26 Unpatentable 35 U.S.C. § 318(a) FINAL

Other: Hearing transcript OTHER

Exhibit 3002 Exhibit

Exhibit 3001 Exhibit

Patent Owner's Statement of Objections to Petitioner's Demonstratives OTHER

Petitioner's Objections to Patent Owner's Demonstratives OTHER

Patent Owner's Updated Exhibit List NOTICE

Ex. 1083 - Petitioner's Demonstratives for Oral Hearing Exhibit

Ex. 2388 - Patent Owner's Demonstratives for Oral Hearing Exhibit

Petitioner's Updated Exhibit List NOTICE

Patent Owner's Reply to Opposition to Motion to Exclude REPLY

Petitioner's Opposition to Patent Owner's Motion to Exclude OPPOSITION

Ex. 1082 - ASM Standard, PTAB-IPR2019-00369, Exhibit 1014 Exhibit

ORDER Setting Oral Argument ORDER

Patent Owner's Motion to Exclude MOTION

Patent Owner's Sur-Reply OTHER

Joint Request for Oral Argument OTHER

Patent Owner's Amended Mandatory Notices NOTICE

Memorandum Opinion, N.D.W. Va. Exhibit

Patent Owner's Updated Exhibit List NOTICE

Patent Owner's Second Set of Objections to Petitioner's Exhibits OTHER

Ex. 1070 Do Tr. Exhibit

Ex. 1077 Manning Tr. IPR2021-00881 Exhibit

Ex. 1076 Manning Tr. Exhibit

Ex. 1078 Eylea Label 2016 Exhibit

Ex. 1073 Brown Tr. Exhibit

Ex. 1068 681 FWD Exhibit

Ex. 1069 Do Tr. IPR2022-01225 Exhibit

Ex. 1072 MARINA Eligibility Criteria Exhibit

Reply REPLYTOOPP

Ex. 1081 Klibanov Tr. Exhibit

Ex. 1074 Brown Tr. IPR2022-01225 Exhibit

Ex. 1075 Manning Tr. IPR2022-01225 Exhibit

Ex. 1079 Regeneron 2022 Press Release Exhibit

Ex. 1071 ANCHOR Eligibility Criteria Exhibit

Ex. 1080 WHO 2006 Exhibit

Joint Notice of Stipulation to Modify Schedule NOTICE

Amended Mandatory Notices NOTICE

Amended Power of Attorney NOTICE

ORDER Conditionally Granting Petitioner’s Motion for Admission Pro Hac Vice of Sarah M. Cork 37 C.F.R. § 42.10(c) ORDER

Joint Notice of Stipulation to Modify Schedule NOTICE

Notice of Deposition of Alexander M. Klibanov NOTICE

Pro Hac Vice Motion to Admit Sarah M. Cork MOTION

Cork Declaration ISO PHV Motion Exhibit

Notice of Deposition of Diana V. Do NOTICE

Notice of Deposition of Richard Manning NOTICE

Notice of Deposition of David M. Brown NOTICE

Patent Owner's Amended Mandatory Notices NOTICE

ORDER Granting Patent Owner’s Unopposed Motion for Entry of Default Protective Order 37 C.F.R. § 42.54 ORDER

ORDER Conditionally Granting Petitioner’s Motions for Admission pro hac vice of Zachariah Summers and Elliot Choi 37 C.F.R. § 42.10(c) ORDER

Ex. 2180 - Miller 2020 Exhibit

Ex. 2067 - Hirokawa 1988 Exhibit

Ex. 2034 - FiercePharma 2021 Exhibit

Ex. 2058 - Manning Declaration Exhibit

Ex. 2089 - Stewart & Rosenfeld 2008 Exhibit

Ex. 2195 - FocusVision - Survey Sample Size How Much Do I Need Exhibit

Ex. 2039 - Eylea Marketing Material Nov. 2013 part 2 of 2 Exhibit

Ex. 2032 - Regeneron Press Release Feb. 14, 2013 Exhibit

Ex. 2293 - Margolis 2010 Exhibit

Ex. 2085 - UNIPROT - P35968 v127 -2011-01-11 Exhibit

Ex. 2079 - UNIPROT - P17948 VGFR1 Human Exhibit

Ex. 2080 - UNIPROT - P17948 v140 -2011-01-11 Exhibit

Ex. 2087 - US Pub 2006_0058234 A1 Exhibit

Ex. 2289 - Retinal Physician Symposium Exhibit

Ex. 2314 - FDA Guidance -Expedited Programs Exhibit